Sichuan Kelun-Biotech Biopharmaceutical Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	36,324	22,555	-	-
Enterprise Value	33,265	20,931	-	-
Last Close Price	163.00	102.90	-	-
PS Ratio	17.58	13.29	-	-
PB Ratio	10.53	8.79	-	-
P/TBV Ratio	10.72	8.79	-	-
P/OCF Ratio	-	343.75	-	-
EV/Sales Ratio	16.49	12.33	-	-
Debt / Equity Ratio	0.01	0.03	-0.93	-0.90
Asset Turnover	0.59	0.68	0.89	-
Inventory Turnover	9.41	13.00	5.36	-
Quick Ratio	5.51	2.35	0.05	0.04
Current Ratio	5.70	2.53	0.08	0.09
Return on Assets (ROA)	-3.59%	-12.59%	-27.27%	-
Return on Capital (ROIC)	-8.18%	-26.04%	-	-
Earnings Yield	-0.68%	-2.80%	-	-
FCF Yield	-1.64%	-0.10%	-	-
Buyback Yield / Dilution	-75.62%	-92.24%	-3.31%	-
Total Shareholder Return	-75.62%	-92.24%	-3.31%	-

Source: S&P Capital IQ. Standard template. Financial Sources.